Synthesis and characterization of novel catalysts enhanced electron transfer in organic halides, highlighting their potential in reductive dehalogenation.
The synthesis and characterization of a series of donor-acceptor diazabenz[cd]fluoranthenium derivatives (PC1-PC8) are reported. Spectroscopic and computational studies reveal that compound PC4, which features a carbazole-donor (D) and fluoranthenium-acceptor (A) cationic scaffold with CB₉H₁₀⁻ as the counteranion, exhibits a 3-fold enhancement in the molar extinction coefficient at 400 nm relative to its parent compound PC8, along with a broad absorption across the visible and ultraviolet regions. Furthermore, the pronounced intramolecular charge transfer (ICT) effect induced by this architecture gives rise to a substantial Stokes shift of 7143 cm⁻¹ for the compound. Transient absorption spectroscopy resolves the dynamics of picosecond electron transfer between the *PC4 (*Cz-diNFluo⁺) and DIPEA, evidenced by the rapid decay of the S₁ state and the concomitant formation of the reduced radical species (Cz-diNFluȯ). The application of PC4 in the reductive dehalogenation of organic halides is also disclosed. The reaction proceeds via a consecutive photoinduced electron transfer (ConPET) mechanism, establishing a potent reducing platform far exceeding the thermodynamic limits of a single excitation event. This reducing ability is directly demonstrated by the efficient dehalogenative conversion of diverse substrates, including aryl bromides, alkyl bromides, and even recalcitrant aryl chlorides.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: